Literature DB >> 27500591

Evidence for and Against Genetic Predispositions to Acute and Chronic Altitude Illnesses.

Martin J MacInnis1, Michael S Koehle2,3.   

Abstract

MacInnis, Martin J., and Michael S. Koehle. Evidence for and against genetic predispositions to acute and chronic altitude illnesses. High Alt Med Biol. 17:281-293, 2016.-Humans exhibit marked variation in their responses to hypoxia, with susceptibility to acute and chronic altitude illnesses being a prominent and medically important example. Many have hypothesized that genetic differences are the cause of these variable responses to hypoxia; however, until recently, these hypotheses were based primarily on small (and sometimes anecdotal) reports pertaining to apparent differences in altitude illness susceptibility between populations, the notion that a history of altitude illness is indicative of subsequent risk, the heritability of hypoxia-related traits, and candidate gene association studies. In the past 5 years, the use of genomic techniques has helped bolster the claim that susceptibility to some altitude illnesses is likely the result of genetic variation. For each of the major altitude illnesses, we summarize and evaluate the evidence stemming from three important characteristics of a genetic trait: (1) individual susceptibility and repeatability across assessments, (2) biogeographical differences and familial aggregation, and (3) association(s) with genetic variants. Evidence to support a genetic basis for susceptibilities to acute mountain sickness (AMS) and high-altitude cerebral edema (HACE) is limited, owing partially to the subjective and unclear phenotype of AMS and the rarity and severity of HACE. In contrast, recent genomic studies have identified genes that influence susceptibility to high-altitude pulmonary edema, chronic mountain sickness, and high-altitude pulmonary hypertension. The collection of more individual, familial, and biogeographical susceptibility data should improve our understanding of the extent to which genetic variation contributes to altitude illness susceptibility, and genomic and molecular investigations have the potential to elucidate the mechanisms that underpin altitude illness susceptibility.

Entities:  

Keywords:  acclimatization; acute mountain sickness; adaptation; chronic mountain sickness; high-altitude cerebral edema; high-altitude pulmonary edema; high-altitude pulmonary hypertension

Mesh:

Year:  2016        PMID: 27500591     DOI: 10.1089/ham.2016.0024

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  7 in total

1.  Acute mountain sickness, arterial oxygen saturation and heart rate among Tibetan students who reascend to Lhasa after 7 years at low altitude: a prospective cohort study.

Authors:  Espen Bjertness; Tianyi Wu; Hein Stigum; Per Nafstad
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

2.  EPAS1 and VEGFA gene variants are related to the symptoms of acute mountain sickness in Chinese Han population: a cross-sectional study.

Authors:  Ji-Hang Zhang; Yang Shen; Chuan Liu; Jie Yang; Yuan-Qi Yang; Chen Zhang; Shi-Zhu Bian; Jie Yu; Xu-Bin Gao; Lai-Ping Zhang; Jing-Bin Ke; Fang-Zheng-Yuan Yuan; Wen-Xu Pan; Zhi-Nian Guo; Lan Huang
Journal:  Mil Med Res       Date:  2020-07-27

3.  The relationship between anxiety and acute mountain sickness.

Authors:  Christopher J Boos; Malcolm Bass; John P O'Hara; Emma Vincent; Adrian Mellor; Luke Sevier; Humayra Abdul-Razakq; Mark Cooke; Matt Barlow; David R Woods
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

4.  Expression Profiles of Long Noncoding RNAs in Mice with High-Altitude Hypoxia-Induced Brain Injury Treated with Gymnadenia conopsea (L.) R. Br.

Authors:  Yongcang Zhang; Lan Liu; Cuiting Liang; Lingyu Zhou; Lixia Tan; Yonghua Zong; Lili Wu; Tonghua Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-12       Impact factor: 2.570

5.  The Role of Salivary miR-134-3p and miR-15b-5p as Potential Non-invasive Predictors for Not Developing Acute Mountain Sickness.

Authors:  He Huang; Huaping Dong; Jianyang Zhang; Xianfeng Ke; Peng Li; Erlong Zhang; Gang Xu; Bingda Sun; Yuqi Gao
Journal:  Front Physiol       Date:  2019-07-16       Impact factor: 4.566

6.  Association between ACTN3 and acute mountain sickness.

Authors:  Ricardo Muller Bottura; Giscard Humberto Oliveira Lima; Debora Cristina Hipolide; João Bosco Pesquero
Journal:  Genes Environ       Date:  2019-12-10

7.  Integrative analysis of miRNA-mRNA network in high altitude retinopathy by bioinformatics analysis.

Authors:  Tong Su; Chufeng Gu; Deji Draga; Chuandi Zhou; Thashi Lhamo; Zhi Zheng; Qinghua Qiu
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.